173 related articles for article (PubMed ID: 24948689)
21. Multiple sclerosis associated with uveitis in two large clinic-based series.
Biousse V; Trichet C; Bloch-Michel E; Roullet E
Neurology; 1999 Jan; 52(1):179-81. PubMed ID: 9921871
[TBL] [Abstract][Full Text] [Related]
22. Benign multiple sclerosis in Crete.
Mastorodemos V; Nikolakaki H; Tzagournissakis M; Kotzamani D; Panou T; Spanaki C; Klados G; Maris T; Kontolaimaki E; Psaroudaki K; Chlouverakis G; Georgakakis G; Plaitakis A
Mult Scler; 2010 Jun; 16(6):701-6. PubMed ID: 20237192
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital.
Alroughani R; Ashkanani A; Lamdhade S
Int J Neurosci; 2012 Feb; 122(2):82-7. PubMed ID: 21985585
[TBL] [Abstract][Full Text] [Related]
24. Patient reported outcomes in benign multiple sclerosis.
Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
[TBL] [Abstract][Full Text] [Related]
25. [Prognostics factors of renal failure in multiple sclerosis].
Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance and prognostic value of serum autoantibody tests in multiple sclerosis.
Öncel S; Şule Dalkılıç Ş; Sayan S; Darol E; Zafer A; Kara D; Tunç A
Neurol Neurochir Pol; 2024; 58(1):60-65. PubMed ID: 37466321
[TBL] [Abstract][Full Text] [Related]
27. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
Roxburgh RH; Seaman SR; Masterman T; Hensiek AE; Sawcer SJ; Vukusic S; Achiti I; Confavreux C; Coustans M; le Page E; Edan G; McDonnell GV; Hawkins S; Trojano M; Liguori M; Cocco E; Marrosu MG; Tesser F; Leone MA; Weber A; Zipp F; Miterski B; Epplen JT; Oturai A; Sørensen PS; Celius EG; Lara NT; Montalban X; Villoslada P; Silva AM; Marta M; Leite I; Dubois B; Rubio J; Butzkueven H; Kilpatrick T; Mycko MP; Selmaj KW; Rio ME; Sá M; Salemi G; Savettieri G; Hillert J; Compston DA
Neurology; 2005 Apr; 64(7):1144-51. PubMed ID: 15824338
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of restless legs syndrome in multiple sclerosis.
Manconi M; Fabbrini M; Bonanni E; Filippi M; Rocca M; Murri L; Ferini-Strambi L
Eur J Neurol; 2007 May; 14(5):534-9. PubMed ID: 17437613
[TBL] [Abstract][Full Text] [Related]
29. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
Tamam Y; Tasdemir N; Yalman M; Tamam B
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
[TBL] [Abstract][Full Text] [Related]
30. Prognostic indicators for long-term disability in multiple sclerosis patients.
Damasceno A; Von Glehn F; Brandão CO; Damasceno BP; Cendes F
J Neurol Sci; 2013 Jan; 324(1-2):29-33. PubMed ID: 23073568
[TBL] [Abstract][Full Text] [Related]
31. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
D'hooghe MB; Haentjens P; Nagels G; De Keyser J
Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
[TBL] [Abstract][Full Text] [Related]
32. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
[TBL] [Abstract][Full Text] [Related]
33. Cigarette smoking and progression in multiple sclerosis.
Koch M; van Harten A; Uyttenboogaart M; De Keyser J
Neurology; 2007 Oct; 69(15):1515-20. PubMed ID: 17923613
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of 'poor sleep' among patients with multiple sclerosis: an independent predictor of mental and physical status.
Merlino G; Fratticci L; Lenchig C; Valente M; Cargnelutti D; Picello M; Serafini A; Dolso P; Gigli GL
Sleep Med; 2009 Jan; 10(1):26-34. PubMed ID: 18207453
[TBL] [Abstract][Full Text] [Related]
35. Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
Wynia K; van Wijlen AT; Middel B; Reijneveld SA; Meilof JF
Mult Scler; 2012 May; 18(5):654-61. PubMed ID: 21965423
[TBL] [Abstract][Full Text] [Related]
36. Natural history of multiple sclerosis in a population-based cohort.
Debouverie M; Pittion-Vouyovitch S; Louis S; Guillemin F;
Eur J Neurol; 2008 Sep; 15(9):916-21. PubMed ID: 18637953
[TBL] [Abstract][Full Text] [Related]
37. Limb apraxia in multiple sclerosis: prevalence and impact on manual dexterity and activities of daily living.
Kamm CP; Heldner MR; Vanbellingen T; Mattle HP; Müri R; Bohlhalter S
Arch Phys Med Rehabil; 2012 Jun; 93(6):1081-5. PubMed ID: 22464095
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of patients with multiple sclerosis using a combination of morphometrical features and clinical scores.
Varoğlu AO; Odaci E; Gumus H; Keles ON; Unal B; Deniz O
J Clin Neurosci; 2010 Feb; 17(2):191-5. PubMed ID: 20036126
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes following surgical management of coexistent cervical stenosis and multiple sclerosis: a cohort-controlled analysis.
Lubelski D; Abdullah KG; Alvin MD; Wang TY; Nowacki AS; Steinmetz MP; Ransohoff RM; Benzel EC; Mroz TE
Spine J; 2014 Feb; 14(2):331-7. PubMed ID: 24239804
[TBL] [Abstract][Full Text] [Related]
40. Vascular comorbidities in the onset and progression of multiple sclerosis.
Tettey P; Simpson S; Taylor BV; van der Mei IA
J Neurol Sci; 2014 Dec; 347(1-2):23-33. PubMed ID: 25454639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
